Open-access Optimization and workflow of in vitro culture of adult Fasciola hepatica

Otimização e fluxo de trabalho da cultura in vitro de Fasciola hepatica adulta

Abstract

The aim of this study was to evaluate different transportation and incubation conditions to test the viability of adult Fasciola hepatica in order to propose a new cultivation workflow. The adult stage of F. hepatica was obtained from naturally infected cattle at a local slaughterhouse in Lima, Peru. Different transport and incubation conditions of F. hepatica were tested, evaluating its viability through a motility scale. DMEM and RPMI 1640 media presented better transport conditions compared to Hedon-Fleig and PBS media (p < 0.001), maintaining the flukes at 37°C. Also, DMEM and RPMI-1640 media presented better incubation conditions compared to Hedon-fleig (p < 0.001). A minimum of 3 ml of medium per fluke was required to maintain best viability (p < 0.001) and no differences in viability were found between the different types of culture plates (p > 0.05). In addition, we found that incubation with DMSO (dimethyl sulfoxide) at concentrations greater than 0.5% v/v for 48 hours generates toxicity (p < 0.001). In conclusion, RPMI 1640 and DMEN media presented better transport and in vitro cultivation conditions for F. hepatica, using DMSO at concentrations lower than 0.5% v/v.

Keywords:
In vitro; Fasciola hepatica; culture media; DMSO

Resumo

O objetivo deste estudo foi avaliar diferentes condições de transporte e incubação, para testar a viabilidade de Fasciola hepatica adulta, a fim de propor um novo fluxo de cultivo. O estágio adulto de F. hepatica foi obtido de bovinos, naturalmente infectados, em um matadouro local em Lima, Peru. Foram testadas várias condições de transporte e incubação de F. hepatica, avaliando sua viabilidade por meio de uma escala de motilidade. Os meios DMEM e RPMI 1640 apresentaram melhores condições de transporte em comparação com os meios Hedon-Fleig e PBS (p < 0,001), mantendo os vermes a 37°C. Além disso, os meios DMEM e RPMI-1640 apresentaram melhores condições de incubação em comparação ao Hedon-fleig (p < 0,001). Foi necessário um mínimo de 3 ml de meio por verme para manter a melhor viabilidade (p < 0,001) e não foram encontradas diferenças na viabilidade entre os diferentes tipos de placas de cultura (p > 0,05). Além disso, foi constatado que a incubação com DMSO (dimetilsulfóxido) em concentrações superiores a 0,5% v/v, por 48 horas, gera toxicidade (p < 0,001). Conclui-se que os meios RPMI 1640 e DMEN apresentaram melhores condições de transporte e cultivo in vitro para F. hepatica, utilizando DMSO em concentrações inferiores a 0,5% v/v.

Palavras-chave:
In vitro; Fasciola hepatica; meio de cultura; DMSO

Introduction

Fasciolosis is a cosmopolitan parasitic disease that affects human and animal health. It is caused by Fasciola hepatica, a trematode whose intermediate hosts are snails of the family Lymnaeidae and definitive hosts are the herbivorous mammals and humans (Livia-Córdova et al., 2021; Alsulami et al., 2023; Juhasz et al., 2023; Rosas-Hostos Infantes et al., 2023). This parasite causes hepatic injuries and results in significant economic losses in the global livestock sector. These losses are estimated to be 3.2 billion dollars per year due to liver confiscation, reduced productivity, and veterinary (Rashid et al., 2019).

Furthermore, the zoonosis risk of fasciolosis is high. It has been estimated that fasciolosis affects approximately 2.4 million people worldwide, mainly in rural areas of the Andean highlands (Caravedo & Cabada, 2020). In parasitized humans, it causes abdominal pain, jaundice and fever (Pfeifer et al., 2019), anemia and cirrhosis (Lopez et al., 2012; Machicado et al., 2016).

Currently, fasciolosis control faces different challenges such as drug resistance (Romero et al., 2019; Morales et al., 2021; Larroza et al., 2023), difficulties in diagnosis (Aftab et al., 2024) and emerging cases that call for investigation. Therefore, in vitro studies are essential for the research on diagnosis and treatment. Parasite cultivation techniques constitute basic elements for first steps research in those areas. Currently, there is no specific culture media for F.hepatica, but the use of different cell culture media such as Hedon-Fleigh (Singh et al., 2009), RPMI 1640 (Duthaler et al., 2010; Jeyathilakan et al., 2012; Ullah et al., 2017; Machicado et al., 2019) and M-199 (Tansatit et al., 2012), has been reported. However, the supplements used vary in each study and details of the culture process (transport, sterilization, management flukes, etc.) for successful cultivation, have not been reported in the literature. In addition, in the F. hepatica drug testing assay, DMSO in one of the most used solvents; however, it can be toxic (Yi et al., 2017) and it is necessary to know its effect on F. hepatica cultivation. Therefore, the aim of this study is to evaluate the viability of F. hepatica under different transport and incubation conditions to propose a specific workflow for the culture of F. hepatica.

Material and Methods

Due to the lack of detail in the literature, all transport and cultivation conditions were proposed by this research group, except for the culture media, temperature and microaerophilic conditions, that have already been published (Tansatit et al., 2012; Ullah et al., 2017; Machicado et al., 2019).

Parasite collection

Adult F. hepatica (Valero et al., 2012) were collected directly from the bile ducts of naturally infected cattle that were slaughtered in the slaughterhouse “Frigorífico Camal San Pedro” in Lima, Peru. Groups of fifteen adult flukes were collected from 37 different cattle. Fasciola gigantica is not reported in Peru, therefore only F. hepatica was collected. Samples were collected by non-probabilistic convenience sampling, collecting the flukes according to the order of arrival of parasitized animals. The sampling was carried out from June to August 2021.

Transport

Various conditions were tested for the transport of F. hepatica from the slaughterhouse to the laboratory (average travel time of 3 hours). DMEM (Dulbecco′s Modified Eagle′s Medium – Sigma Aldrich), Hedon-Fleig (18), RPMI 1640 (Sigma – Aldrich, USA) and PBS were evaluated as transport media. All the media were supplemented with penicillin at 1000 IU/ml and gentamicin at 0.1 mg/ml under sterile conditions. Various thermal conditions were evaluated for their transport: 18 ± 2 °C (environmental temperature according to the Peruvian national weather authority - SENAMHI), 37 ± 2 °C and temperatures higher than 39 °C (until 50°C). 15 adult flukes were placed and transported for each sterile 50ml Falcon tubes containing 40ml of the transport media. The falcon tubes were stored in thermal boxes. All adult F. hepatica were transported to the laboratory immediately after their collection from the bile ducts. Viability was evaluated immediately upon arrival at the laboratory, during the washing process before cultivation. Each transport condition was evaluated in duplicate.

Washing

The washing and cultivation processes were performed in the Laboratory of Research of Infectious Diseases at Universidad Peruana Cayetano Heredia. All collected flukes were washed before cultivation. This process was carried out twice with Hedon-Fleig media supplemented with antibiotics (penicillin at 1000 IU/ml and gentamicin at 0.1 mg/ml) and a last wash was carried out with the same media to be incubated for adaptation. The washing and culture media were maintained at 37°C during the entire process.

Cultivation

For the cultivation of F. hepatica, three types of culture media were evaluated: DMEM, Hedon-Fleig and RPMI-1640. Initially 9 ml of culture media per fluke were incubated in petri dishes for up to 7 days to determinate the maximum in vitro survival days. Then, volumes of culture media per fluke (2, 2.5, 3, 4 and 5 ml per well) were evaluated using the best culture media selected in the previous step. Also, different types of culture plates were compared, evaluating 6-well culture plates (with a cell growth area of 9.5 cm2 and a maximum volume of 17 ml per well) and 24-well culture plates (with a cell growth area of 1.9 cm2 and a maximum volume of 3.5 ml per well). The evaluations of types of culture were conducted using the optimal culture media volume previously selected. Additionally, the influence of DMSO on the viability of F. hepatica was evaluated by analyzing concentrations of 0.2, 0.5, 1, 5 and 10% (v/v) in the RPMI-1640 media. Each cultivation condition was evaluated in duplicates.

All cultivations were performed at 37°C, with 5% CO2 and 95% humidity (Duthaler et al., 2010; Ullah et al., 2017; Machicado et al., 2019). All the media were kept in sterile conditions, with a pH of 7.4, and were supplemented with penicillin at 1000 IU/ml and gentamicin at 0.1 mg/ml. The entire process of washing and preparation of the F. hepatica culture was carried out in laminar flow cabinets under sterile conditions.

Viability evaluation

The viability of F. hepatica was evaluated by the research team and a motility score with the following scale was used:

  • 3 – Good motility (fast movements with good intensity)

  • 2 – Reduced motility (slow movements with low intensity, reduced by 50%).

  • 1 – Very reduced motility (moves only parts of the body, generally in peripheral areas).

  • 0 – Immobile and dead (shows total paralysis and pale coloration, confirmed with a 10X stereoscope).

This motility scale was applied after the washing and incubation process.

Statistical analyzes

Descriptive statistical of motility score was presented by median, interquartile range, minimum and maximum values. Differences of motility score between different cultivation conditions was evaluated by using the Kruskal-Wallis test and Dunn´s post-hoc test. P < 0.05 was considered as statistically significant. All statistical analysis was performed with the Stata software (StataCorp LP, College Station, TX).

Results

Transport

The RPMI, DMEM, Hedon-Fleig and PBS media maintained good viability of adult flukes during transport while the temperature of the culture media was approximately of 37°C, showing best viability in RPMI and DMEN media (p < 0.001). However, at temperatures higher than 39°C and at environmental temperature, the viability was low, showing better viability RPMI, DMEN and Hedon-Fleig media (motility score = 1) compared with PBS (motility score = 0; p < 0.001; Table 1).

Table 1
Assessment of the viability in the transport of the adult stage of Fasciola hepatica under different conditions.

Cultivation

The Hedon-Fleig media maintained the viability of the adult stages of F. hepatica with a median life of 4 days, reaching maximum survival values of 6 days; while the RPMI and DMEM media kept F. hepatica alive with a median of 5 days, reaching maximum values of up to 7 days of life. All F. hepatica remained alive for at least 48 hours in all the culture media. Based on this result, all evaluations were performed for 48 hours. The evaluation of culture media during 48 hours of incubation showed that RPMI 1640 and DMEM media maintained the maximum viability (motility score 3) in contrast to Hedon-Fleig media (motility score 2; p<0.001). Regarding culture density, F. hepatica survived up to 48 hours incubation with high viability, with a minimum of 3 ml of culture media per adult fluke (p < 0.001), requiring media replacement for longer culture or to increase the initial volume of culture media. Also, no difference was found between 6- and 24-well culture plates (p > 0.05); F. hepatica could survive in both culture plates with high viability (motility score 3; Table 2).

Table 2
Assess of the in vitro viability of Fasciola hepatica according to the culture media, volume of the culture media, type of plate used and DMSO concentration.

The DMSO concentration added to the culture showed that F. hepatica remained viable (motility score 3) until 0.2% v/v at 48h of incubation, but higher concentration reduced the viability up to the total paralysis of flukes (p < 0.05; Table 2).

Based on these results, we propose a workflow for the cultivation of F. hepatica (Figure 1). It is recommended that the entire culture process be conducted under sterile conditions, as contamination could result in incubation failure. In addition, heat shock of the flukes must also be avoided during the entire transport, washing and incubation process.

Figure 1
In vitro culture workflow of adult stage of Fasciola hepatica.

Discussion

According to our results, the transportation an incubation of F. hepatica can be carried out with various culture media. This diversity of media used is widely reported in the scientific literature (Singh et al., 2009; Duthaler et al., 2010; Tansatit et al., 2012). However, in this study, media such as RPMI 1640 and DMEM were found to be more suitable in maintaining F. hepatica with good viability under in vitro conditions, probably due to the diversity of its components (carbohydrates, amino acids, vitamins and minerals), necessary for parasite survival (Cantor, 2019).

Even though the DMEM and RPMI 1640 media showed great efficiency for transport and cultivation, the working group agreed that the RPMI 1640 media generated better motility of F. hepatica with respect to the DMEM media, both in transport and in incubation. However, they are very subtle differences, hard to establish on a motility scale that can even include some subjectivity. We also suggest washing the parasites with the culture media, to help maintain good viability of F.hepatica during this stressful process. Finally, the temperature is a fundamental factor for viability during the transport and washing process, since it is a simulation of in vivo conditions. Therefore, thermal shocks must be avoided, and it is suggested to keep the flukes at temperatures close to 37°C during the entire process.

F. hepatica was able to survive without difficulty in both the 6- and the 24-well culture plates. These results are based on the normal living conditions in the livers of naturally infected animals, where they live compressed in the bile ducts with other flukes, mineral deposits and the passage of the bile (Caravedo & Cabada, 2020). This condition was also documented in another study, where 12-well culture plates were successfully used for the incubation of F. hepatica (Duthaler et al., 2010). This evidence confirms the versatility of F. hepatica for in vitro cultivation in different types of culture plates.

DMSO is an organic solvent for polar and nonpolar solutions, widely used in pharmacology and toxicology studies (Modrzyński et al., 2019); nevertheless, DMSO can have toxic effects in blood and endothelial cells in vitro analysis at 0.6% concentration (Yi et al., 2017). We showed that DMSO begins to generate toxicity in F. hepatica at concentrations of 0.5% at 48 hours of incubation, thus, various in vitro studies in Fasciola spp. use a concentration of 0.1% of DMSO (Tansatit et al., 2012; Ullah et al., 2017), which we have shown to be a non-toxic concentration.

This study successfully identified optimal conditions for transport and culture of F.hepatica, but it has its limitations. Firstly, the flukes were acquired from a slaughterhouse, so we did not have access to information regarding treatment of the animals with antiparasitic drugs (albendazole, triclabendazole, clorsulon, etc.). Therefore, a motility score was applied in freshly collected flukes and before starting their incubation to ensure the selection of best viable flukes. In addition, flukes from multiple bovines were selected, to avoid sampling from the same possible treated animal. Secondly, the viability assessment could not be executed for more than 48 hours, due to the presence of some dead flukes. However, this evaluation period is enough to evaluate the behavior of different metabolites in vitro taking into account that time to peak drug concentration of many flukicidal drugs are 12 to 40 hours (Ortiz et al., 2014; Rehbein et al., 2024). Despite these challenges, we propose a protocol that maintains high viability of adult F. hepatica throughout the entire culture process. This protocol could be applied for the evaluation of new antiparasitic treatments in vitro.

Conclusion

DMEM, RPMI 1640, Hedon-Fleig and PBS culture media kept F. hepatica viable during the transport process at approximately 37°C. In addition, the DMEM and RPMI 1640 media maintained F. hepatica with the best viability during incubation while the DMSO at 0.5% v/v reduced the viability of F. hepatica during the 48 hours of incubation.

Acknowledgements

The author would like to thank to the Epidemiological Research Doctorate at Universidad Peruana Cayetano Heredia under FONDECYT/CIENCIACTIVA scholarship EF033-235-2015 and supported by training grant D43 TW007393 awarded by the Fogarty International Center of the US National Institutes of Health, for financing this project. To Dr. Manuela Verástegui for the access to the laboratory facilities and to Grace Tan for the help in final English edition.

  • How to cite:
    Burga-Cisterna C, Málaga E, Serrano-Martínez E, Livia-Córdova G, Antezana R, Luna AC, et al. Optimization and workflow of in vitro culture of adult Fasciola hepatica. Braz J Vet Parasitol 2024; 33(4): e014524. https://doi.org/10.1590/S1984-29612024064
  • Ethics declaration
    The present study was approved by the Institutional Review Board of Ethics for Animal Use of the Universidad Peruana Cayetano Heredia (code 104002).

References

  • Aftab A, Raina OK, Maxton A, Masih SA. Advances in diagnostic approaches to Fasciola infection in animals and humans: an overviews. J Helminthol 2024; 98: e12. http://doi.org/10.1017/S0022149X23000950 PMid:38269544.
    » http://doi.org/10.1017/S0022149X23000950
  • Alsulami MN, Mohamed K, Wakid MH, Abdel-Gaber R, Timsah AG, Al-Megrin WAI, et al. Molecular characterization of Fasciola hepatica in sheep based on DNA Sequences of Ribosomal ITS-1. Infect Drug Resist 2023; 16: 6661-6671. http://doi.org/10.2147/IDR.S421206 PMid:37849790.
    » http://doi.org/10.2147/IDR.S421206
  • Cantor JR. The rise of physiologic media. Trends Cell Biol 2019; 29(11): 854-861. http://doi.org/10.1016/j.tcb.2019.08.009 PMid:31623927.
    » http://doi.org/10.1016/j.tcb.2019.08.009
  • Caravedo MA, Cabada MM. Human fascioliasis: current epidemiological status and strategies for diagnosis, treatment, and control. Res Rep Trop Med 2020; 11: 149-158. http://doi.org/10.2147/RRTM.S237461 PMid:33273878.
    » http://doi.org/10.2147/RRTM.S237461
  • Duthaler U, Smith TA, Keiser J. In vivo and in vitro sensitivity of Fasciola hepatica to triclabendazole combined with artesunate, artemether, or OZ78. Antimicrob Agents Chemother 2010; 54(11): 4596-4604. http://doi.org/10.1128/AAC.00828-10 PMid:20733042.
    » http://doi.org/10.1128/AAC.00828-10
  • Jeyathilakan N, Murali K, Anandaraj A, Abdul Basith S. In vitro evaluation of anthelmintic property of ethno-veterinary plant extracts against the liver fluke Fasciola gigantica. J Parasit Dis 2012; 36(1): 26-30. http://doi.org/10.1007/s12639-011-0064-1 PMid:23543611.
    » http://doi.org/10.1007/s12639-011-0064-1
  • Juhasz A, Chapman E, Martin A, Cunningham LJ, Jones S, Johnson B, et al. On liver fluke (Fasciola hepatica) in captive vicuñas (Vicugna vicugna) at knowsley safari, prescot, United Kindom. J Zoo Wildl Med 2023; 54(2): 345-349. http://doi.org/10.1638/2022-0125 PMid:37428698.
    » http://doi.org/10.1638/2022-0125
  • Larroza M, Aguilar M, Soler P, Mora J, Roa M, Cabrera R, et al. Triclabendazole resistance in Fasciola hepatica: first report in sheep from the Santa Cruz province, Argentinian Patagonia. Vet Parasitol Reg Stud Reports 2023; 45: 100927. http://doi.org/10.1016/j.vprsr.2023.100927 PMid:37783530.
    » http://doi.org/10.1016/j.vprsr.2023.100927
  • Livia-Córdova G, Burga-Cisterna C, Quiroz-Dávila A, Rentería-Samamé B, Mercado-Gamarra A, Del Solar-Vela M, et al. Prevalencia y factores de riesgo asociados a la infección por Fasciola hepatica en bovinos de comunidades campesinas de Huancabamba (Piura- Perú). Rev Investig Vet Peru 2021; 32(1): e019510. http://doi.org/10.15381/rivep.v32i1.19510
    » http://doi.org/10.15381/rivep.v32i1.19510
  • Lopez M, White AC Jr, Cabada MM. Burden of Fasciola hepatica infection among children from Paucartambo in Cusco, Peru. Am J Trop Med Hyg 2012; 86(3): 481-485. http://doi.org/10.4269/ajtmh.2012.11-0448 PMid:22403322.
    » http://doi.org/10.4269/ajtmh.2012.11-0448
  • Machicado C, Machicado JD, Maco V, Terashima A, Marcos LA. Association of Fasciola hepatica infection with liver fibrosis, cirrhosis, and cancer: a systematic review. PLoS Negl Trop Dis 2016; 10(9): e0004962. http://doi.org/10.1371/journal.pntd.0004962 PMid:27681524.
    » http://doi.org/10.1371/journal.pntd.0004962
  • Machicado C, Soto MP, Timoteo O, Vaisberg A, Pajuelo M, Ortiz P, et al. Screening the pathogen box for identification of new chemical agents with anti- Fasciola hepatica activity. Antimicrob Agents Chemother 2019; 63(3): e02373-e18. http://doi.org/10.1128/AAC.02373-18 PMid:30602522.
    » http://doi.org/10.1128/AAC.02373-18
  • Modrzyński JJ, Christensen JH, Brandt KK. Evaluation of dimethyl sulfoxide (DMSO) as a co-solvent for toxicity testing of hydrophobic organic compounds. Ecotoxicology 2019; 28(9): 1136-1141. http://doi.org/10.1007/s10646-019-02107-0 PMid:31559559.
    » http://doi.org/10.1007/s10646-019-02107-0
  • Morales ML, Tanabe MB, White AC Jr, Lopez M, Bascope R, Cabada MM. Triclabendazole treatment failure for Fasciola hepatica infection among preschool and school-age children, Cusco, Peru. Emerg Infect Dis 2021; 27(7): 1850-1857. http://doi.org/10.3201/eid2707.203900 PMid:34152949.
    » http://doi.org/10.3201/eid2707.203900
  • Ortiz P, Castope N, Cabrera M, Farias C, Suarez G, Lanusse C, et al. Pharmacokinetic evaluation of different generic triclabendazole formulations in heifers. N Z Vet J 2014; 62(5): 279-285. http://doi.org/10.1080/00480169.2014.925411 PMid:24861276.
    » http://doi.org/10.1080/00480169.2014.925411
  • Pfeifer CM, Bourm KS, Brandt MA, Ali K. Liver fluke-induced choledocholithiasis with biliary ductal obstruction. Radiol Case Rep 2019; 14(12): 1483-1486. http://doi.org/10.1016/j.radcr.2019.09.022 PMid:31641397.
    » http://doi.org/10.1016/j.radcr.2019.09.022
  • Rashid M, Rashid MI, Akbar H, Ahmad L, Hassan MA, Ashraf K, et al. A systematic review on modelling approaches for economic losses studies caused by parasites and their associated diseases in cattle. Parasitology 2019; 146(2): 129-141. http://doi.org/10.1017/S0031182018001282 PMid:30068403.
    » http://doi.org/10.1017/S0031182018001282
  • Rehbein S, Kvaternick V, Kellermann M, Hamel D, Antretter A, Johnson C. Plasma pharmacokinetics of clorsulon following administration of a single subcutaneous or intravenous injection to cattle. J Vet Pharmacol Ther 2024; 47(2): 87-94. http://doi.org/10.1111/jvp.13410 PMid:37823356.
    » http://doi.org/10.1111/jvp.13410
  • Romero J, Villaguala C, Quiroz F, Landaeta-Aqueveque C, Alfaro G, Pérez R. Flukicide efficacy against Fasciola hepatica of Triclabendazole and Nitroxynil in cattle of the central valley of Chile. Rev Bras Parasitol Vet 2019; 28(1): 164-167. http://doi.org/10.1590/s1984-296120180089 PMid:30892461.
    » http://doi.org/10.1590/s1984-296120180089
  • Rosas-Hostos Infantes LR, Paredes Yataco GA, Ortiz-Martínez Y, Mayer T, Terashima A, Franco-Paredes C, et al. The global prevalence of human fascioliasis: a systematic review and meta-analysis. Ther Adv Infect Dis 2023; 10: 20499361231185413. http://doi.org/10.1177/20499361231185413 PMid:37434654.
    » http://doi.org/10.1177/20499361231185413
  • Singh TU, Kumar D, Tandan SK, Mishra SK. Inhibitory effect of essential oils of Allium sativum and Piper longum on spontaneous muscular activity of liver fluke, Fasciola gigantica. Exp Parasitol 2009; 123(4): 302-308. http://doi.org/10.1016/j.exppara.2009.08.002 PMid:19679128.
    » http://doi.org/10.1016/j.exppara.2009.08.002
  • Tansatit T, Sahaphong S, Riengrojpitak S, Viyanant V, Sobhon P. Fasciola gigantica: the in vitro effects of artesunate as compared to triclabendazole on the 3-weeks-old juvenile. Exp Parasitol 2012; 131(1): 8-19. http://doi.org/10.1016/j.exppara.2012.02.018 PMid:22425749.
    » http://doi.org/10.1016/j.exppara.2012.02.018
  • Ullah R, Rehman A, Zafeer MF, Rehman L, Khan YA, Hannan Khan MA, et al. Anthelmintic potential of thymoquinone and curcumin on Fasciola gigantica. PLoS One 2017; 12(2): e0171267. http://doi.org/10.1371/journal.pone.0171267 PMid:28152102.
    » http://doi.org/10.1371/journal.pone.0171267
  • Valero MA, Perez-Crespo I, Khoubbane M, Artigas P, Panova M, Ortiz P, et al. Fasciola hepatica phenotypic characterization in Andean human endemic areas: valley versus altiplanic patterns analysed in liver flukes from sheep from Cajamarca and Mantaro, Peru. Infect Genet Evol 2012; 12(2): 403-410. http://doi.org/10.1016/j.meegid.2012.01.009 PMid:22285769.
    » http://doi.org/10.1016/j.meegid.2012.01.009
  • Yi X, Liu M, Luo Q, Zhuo H, Cao H, Wang J, et al. Toxic effects of dimethyl sulfoxide on red blood cells, platelets, and vascular endothelial cells in vitro. FEBS Open Bio 2017; 7(4): 485-494. http://doi.org/10.1002/2211-5463.12193 PMid:28396834.
    » http://doi.org/10.1002/2211-5463.12193

Publication Dates

  • Publication in this collection
    22 Nov 2024
  • Date of issue
    2024

History

  • Received
    23 July 2024
  • Accepted
    28 Aug 2024
location_on
Colégio Brasileiro de Parasitologia Veterinária FCAV/UNESP - Departamento de Patologia Veterinária, Via de acesso Prof. Paulo Donato Castellane s/n, Zona Rural, , 14884-900 Jaboticabal - SP, Brasil, Fone: (16) 3209-7100 RAMAL 7934 - Jaboticabal - SP - Brazil
E-mail: cbpv_rbpv.fcav@unesp.br
rss_feed Acompanhe os números deste periódico no seu leitor de RSS
Ir para o topo Reportar erro